超聲乳化白內(nèi)障術(shù)后黃斑區(qū)光學(xué)相干斷層掃描觀察
【摘要】 目的:應(yīng)用三維光學(xué)相干斷層掃描儀觀察白內(nèi)障術(shù)后黃斑區(qū)結(jié)構(gòu)的影像學(xué)特征。方法:回顧性分析我院200911/201002行超聲乳化白內(nèi)障手術(shù)且術(shù)中無并發(fā)癥的32例46眼單純老年性白內(nèi)障患者,記錄術(shù)后視力、眼前段和眼底情況,術(shù)后1mo行三維光學(xué)相干斷層掃描(Topcon3D OCT1000)檢測。結(jié)果:白內(nèi)障患者46眼均成功施行超聲乳化吸除術(shù),術(shù)后視力均有不同程度提高;術(shù)后1mo從三維OCT中未發(fā)現(xiàn)明顯黃斑區(qū)結(jié)構(gòu)的改變且檢測到黃斑中心凹視網(wǎng)膜平均厚度(CMT)為(217.34±36.15)μm,較正常同年齡人群組黃斑中心凹視網(wǎng)膜平均厚度CMT為(195.87±40.87)μm略增加,但兩者經(jīng)統(tǒng)計學(xué)處理未見明顯差異(P=0.284);少數(shù)視力和視功能恢復(fù)略差的患者其OCT中表現(xiàn)為光感受器內(nèi)外節(jié)連接(IS/OS)層的連續(xù)性及視網(wǎng)膜色素上皮(RPE)的完整性欠佳。結(jié)論:無全身及眼部其他疾病的老年性白內(nèi)障患者,術(shù)后1mo黃斑區(qū)結(jié)構(gòu)基本與正常人群相同,部分患者出現(xiàn)視網(wǎng)膜后極部IS/OS和RPE連續(xù)性和完整性的輕度變化,因而使術(shù)后患者視力尤其是視功能質(zhì)量的提高受到影響。
【關(guān)鍵詞】 超聲乳化/白內(nèi)障;視力/視功能;光學(xué)相干斷層掃描法律論文發(fā)表
AbstractAIM: To eva luate the imaging features of the macular after phacoemulsification cataract surgery by spectraldomain optical coherence tomography(SDOCT).METHODS:A retrospective series case study. 46 eyes with simple agerelated cataract who had phacoemulsification from Nov.2009 to Feb.2010 in our hospital without any complications during operation were included in this study. Visual acuity, slitlamp examination and fundus were checked. SDOCT(Topcon 3DOCT1000) was used to check retinal structure at 1 month after surgery.RESULTS: Successful cataract surgery was performed in all eyes with postoperative bestcorrected visual acuity(BCVA) improved.SDOCT showed no significant change of the macular thickness except for slight increase of the central macular thickness, which was 217.34±36.15μm compared with195.87±40.87μm of normal people at the same age. There was no statistical difference between surgical group and normal people group. However, the slight abnormal at continuity of the IS/OS layer and integrity of the RPE layer appeared in some poor visual acuity and visual function recovery patients.CONCLUSION: The macular thickness compared with normal people has no significant change after phacoemulsification in simple agerelated cataract patients without other complication before surgery. Some patients at 1 month after surgery with slight poor visual acuity and visual function is probably due to the abnormal of continuity of the IS/OS layer and integrity of the RPE layer.法律論文發(fā)表
KEYWORDS: phacoemulsification/cataract; visual acuity/ function; optical coherence tomography
: 0引言
隨著超聲乳化白內(nèi)障手術(shù)技術(shù)及設(shè)備的不斷完善,手術(shù)并發(fā)癥明顯減少,手術(shù)效果顯著提高[1]。但是,有些術(shù)前視功能預(yù)測良好、術(shù)后眼前部沒有明顯異常的患者并不能獲得滿意的視覺效果[2] ,為了探究其原因,我們對32例46眼白內(nèi)障患者行超聲乳化吸除術(shù)后1mo進行三維光學(xué)相干斷層掃描檢查,觀察黃斑區(qū)的結(jié)構(gòu)特征,分析影響視力恢復(fù)的相關(guān)因素。
1對象和方法
1.1對象 回顧性分析200911/201002在我院行超聲乳化吸除手術(shù)的32例46眼老年性白內(nèi)障患者,其中男18例25眼,女14例21眼;年齡47~81(平均69)歲;術(shù)前視力指數(shù)/眼前~0.4,晶狀體核硬度Ⅰ~Ⅳ級;46眼中均無全身及眼部其他疾病。術(shù)后1mo所有患者均行眼部常規(guī)檢查,包括最佳矯正視力、眼壓、裂隙燈顯微鏡、散瞳后直間接檢眼鏡及三維光學(xué)相干斷層掃描(Topcon 3D OCT1000,日本Topcon公司)檢測。法律論文發(fā)表
1.2方法 散瞳后對所有患眼視網(wǎng)膜黃斑區(qū)進行3DOCT檢測,掃描模式選用512×128,掃描范圍為后極部 6.00mm×6.00mm,掃描速度27000次A掃描/s,探測深度2.3mm,軸向分辨率5μm;結(jié)合相應(yīng)的掃描彩色眼底照片,測量和分析黃斑中心凹部位視網(wǎng)膜的厚度和結(jié)構(gòu)變化。充分散瞳后眼周阻滯麻醉,46眼均做上方透明角膜隧道切口,黏彈劑下連續(xù)環(huán)形撕囊,水分離后采用超聲乳化儀(Legacy2000,美國愛爾康公司)用攔截劈裂法超聲乳化晶狀體核,抽吸晶狀體皮質(zhì),沿后囊膜注入黏彈劑,通過推注器植入疏水性丙烯酸酯一片式折疊式人工晶狀體(MA60MA,Alcon公司)到位,吸凈前房及人工晶狀體后面黏彈劑,水密切口。術(shù)畢結(jié)膜下給予抗菌消炎處理,手術(shù)均順利完成,術(shù)中無并發(fā)癥;術(shù)后典必殊眼液滴眼,4次/d,持續(xù)至術(shù)后15d。手術(shù)均由同一人操作,隨訪1~3mo。
統(tǒng)計學(xué)分析:所有數(shù)據(jù)均采用SAS 8.2統(tǒng)計軟件處理,選用樣本均數(shù)與總體均數(shù)比較的t檢驗分析治療組術(shù)后黃斑中心凹視網(wǎng)膜平均厚度和正常同年齡人群組的黃斑中心凹視網(wǎng)膜平均厚度之間的差異。P<0.05為差異有統(tǒng)計學(xué)意義。
2結(jié)果
2.1視力 所選32例46眼老年性白內(nèi)障患者的視力在術(shù)后1mo檢查時較術(shù)前均有不同程度的提高,術(shù)后1mo最佳矯正視力≥0.6者有36眼(78%),0.3~0.5者有10眼(22%)。
2.2眼部情況 術(shù)后1mo 46眼角膜透明,無炎癥反應(yīng),人工晶狀體位置良好,眼底鏡下未發(fā)現(xiàn)明顯黃斑區(qū)病變。
2.3光學(xué)相干斷層掃描(3DOCT
本站論文資源均為來自網(wǎng)絡(luò)轉(zhuǎn)載,免費提供給廣大作者參考,不進行任何贏利,如有版權(quán)問題,請聯(lián)系管理員刪除! 快速論文發(fā)表網(wǎng)(www.455685.com)本中心和國內(nèi)數(shù)百家期刊雜志社有良好的合作關(guān)系,可以幫客戶代發(fā)論文投稿.
投稿郵箱:ksfbw@126.com
客服Q Q:
82702382
聯(lián)系電話:15295038833
本站論文資源均為來自網(wǎng)絡(luò)轉(zhuǎn)載,免費提供給廣大作者參考,不進行任何贏利,如有版權(quán)問題,請聯(lián)系管理員刪除!